In-vitro and in-vivo antitumour activity of physalins B and D from Physalis angulata.
|
| Abstract |
We have evaluated the in-vitro and in-vivo antitumour activity of physalin B and physalin D isolated from the aerial parts of Physalis angulata. In-vitro, both compounds displayed considerable cytotoxicity against several cancer cell lines, showing IC50 values in the range of 0.58 to 15.18 microg mL(-1) for physalin B, and 0.28 to 2.43 microg mL(-1) for physalin D. The antitumour activity of both compounds was confirmed in-vivo using mice bearing sarcoma 180 tumour cells. The in-vivo antitumour activity was related to the inhibition of tumour proliferation, as observed by the reduction of Ki67 staining in tumours of treated animals. Histopathological examination of the kidney and liver showed that both organs were affected by physalin treatment, but in a reversible manner. These compounds were probably responsible for the previously described antitumour activity of ethanol extracts of P. angulata, and their identification and characterization presented here could explain the ethnopharmacological use of this species in the treatment of cancer.
|
|---|---|
| Authors | Hemerson Iury Ferreira Magalhães, Maria Leopoldina Veras, Márcia Rocha Torres, Ana Paula Negreiros Nunes Alves, Otília Deusdênia Loiola Pessoa, Edilberto Rocha Silveira, Letícia Veras Costa-Lotufo, Manoel Odorico de Moraes, Cláudia Pessoa |
| Journal | The Journal of pharmacy and pharmacology (J Pharm Pharmacol) Vol. 58 Issue 2 Pg. 235-41 (Feb 2006) ISSN: 0022-3573 [Print] England |
| PMID | 16451752 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't) |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!